Dow University of Health and Sciences, Karachi, Pakistan.
J Pak Med Assoc. 2024 Feb;74(2):370-373. doi: 10.47391/JPMA.9020.
Oral squamous cell carcinoma (OSCC) is the most prevalent cancer in Pakistani population because of consumption of different tobacco-containing products whether smoked or chewed. These patients commonly report at a late stage of the disease. The patient's survival only depends upon early-stage diagnosis. Literature has reported that there is an increased tendency of transformation of oral potentially malignant disorder (OPMD) into OSCC. Biopsy is the gold standard measure for diagnosis but for OPMD cases biopsy was not recommended and most of the times the patients were also not willing to have a biopsy done. So, along with the biopsy there is a need for non-invasive protein biomarker that might aid in the early detection of oral cancer as well as highlight the high-risk individuals. This short communication focuses on the role of early diagnostic biomarkers present in literature, such as synuclein-γ (SNCG), Squamous cell carcinoma antigen (SCCAg), p53, MMPs-12, and IL-6. Furthermore, application of these biomarkers in multi-centre longitudinal studies is needed to establish their role as a non-invasive diagnostic biomarker for OSCC.
口腔鳞状细胞癌(OSCC)是巴基斯坦人群中最常见的癌症,因为他们会消费各种含烟草的产品,无论是吸烟还是咀嚼。这些患者通常在疾病晚期才报告。患者的生存仅取决于早期诊断。文献报道,口腔潜在恶性疾病(OPMD)向 OSCC 转化的趋势增加。活检是诊断的金标准措施,但对于 OPMD 病例,不建议进行活检,而且大多数情况下,患者也不愿意进行活检。因此,除了活检外,还需要非侵入性的蛋白质生物标志物,以帮助早期检测口腔癌,并突出高危人群。本简讯重点介绍了文献中存在的早期诊断生物标志物的作用,如突触核蛋白-γ(SNCG)、鳞状细胞癌抗原(SCCAg)、p53、MMPs-12 和 IL-6。此外,需要在多中心纵向研究中应用这些生物标志物,以确立它们作为 OSCC 非侵入性诊断生物标志物的作用。